OSEBX1 929,61−0,80 %
EQNR338,00−3,40 %
DNB282,20+0,39 %
MOWI199,35−1,41 %
Brent$98,97−2,27 %
Gold$4 740,50+0,98 %
USD/NOK9,2193−0,87 %
EUR/NOK10,8519−0,68 %
SPX7 365,12+0,00 %
NDX28 599,17+0,00 %
LIVE · 09:56 UTC
123690$8840.0056

Hankook Cosmetics Co Ltd

Miscellaneous Specialty RetailersVerified
Score breakdown
Valuation+15Profitability+32Sentiment+30
Quality breakdown
Key fields100Profile38Conclusion97AI synthesis40Observations3

Hankook Cosmetics maintains a strong liquidity position, with cash and equivalents amounting to KRW 15,906,436,930, representing 28.2% of total assets. The company's liquidity FPT (free cash flow to total liabilities) is robust, with free cash flow of KRW 2,074,073,840 and total liabilities of KRW 22,807,739,190, resulting in a liquidity buffer that supports operational flexibility [doc:HA-latest]. The current ratio of 1.84 indicates the company can cover its short-term obligations more than once over [doc:valuation snapshot]. Profitability metrics show a mixed picture. The company's return on equity (ROE) of 3.36% and return on assets (ROA) of 2.00% are below the industry median for Personal Care Products, which typically sees ROE in the 5-8% range. Gross profit of KRW 41,900,305,320 represents 49.3% of revenue, but operating income of KRW 527,535,270 is only 0.62% of revenue, indicating high operating costs relative to sales [doc:HA-latest]. The company's revenue is concentrated across two business segments: Cosmetics Sales Business and Other Business. The Cosmetics Sales Business is the primary revenue driver, though the exact proportion is not disclosed. The Other Business segment includes franchise operations and real estate leasing, which may provide diversification but also introduce exposure to non-core revenue streams [doc:HA-latest]. Growth trajectory appears modest. Revenue for the latest period was KRW 85,031,829,900, with no prior-year data provided. The outlook for the current fiscal year (FY) and next FY is not explicitly stated, but the company's capital expenditure of KRW -792,951,780 suggests a focus on cost optimization rather than expansion [doc:HA-latest]. Risk assessment indicates low liquidity and dilution risk. The company has no immediate filing-based liquidity or dilution flags, and its debt-to-equity ratio of 0.16 suggests a conservative capital structure. However, the high price-to-earnings (PE) ratio of 126.01 and price-to-book (PB) ratio of 4.23 indicate that the stock is trading at a premium relative to earnings and book value, which could be a concern if earnings growth does not meet expectations [doc:valuation snapshot]. Recent events include no disclosed material filings or transcripts in the provided data. The company's financials suggest a stable but low-growth business model, with a focus on maintaining liquidity and managing operating costs [doc:HA-latest].

30-day price · 123690+230.00 (+2.8%)
Low$7580.00High$10090.00Close$8550.00As of7 May, 00:00 UTC
Profile
CompanyHankook Cosmetics Co Ltd
Ticker123690.KS
SectorConsumer Cyclicals
BusinessRetailers
Industry groupRetailers
IndustryMiscellaneous Specialty Retailers
AI analysis

Business. Hankook Cosmetics Co Ltd is a Korea-based company primarily engaged in the sale of cosmetics and cosmetic products through its Cosmetics Sales Business segment, while also operating a franchise business and real estate leasing under its Other Business segment [doc:HA-latest].

Classification. Hankook Cosmetics is classified under the Consumer Cyclicals economic sector, Retailers business sector, and Miscellaneous Specialty Retailers industry with a confidence level of 0.92 [doc:verified market data].

Hankook Cosmetics maintains a strong liquidity position, with cash and equivalents amounting to KRW 15,906,436,930, representing 28.2% of total assets. The company's liquidity FPT (free cash flow to total liabilities) is robust, with free cash flow of KRW 2,074,073,840 and total liabilities of KRW 22,807,739,190, resulting in a liquidity buffer that supports operational flexibility [doc:HA-latest]. The current ratio of 1.84 indicates the company can cover its short-term obligations more than once over [doc:valuation snapshot]. Profitability metrics show a mixed picture. The company's return on equity (ROE) of 3.36% and return on assets (ROA) of 2.00% are below the industry median for Personal Care Products, which typically sees ROE in the 5-8% range. Gross profit of KRW 41,900,305,320 represents 49.3% of revenue, but operating income of KRW 527,535,270 is only 0.62% of revenue, indicating high operating costs relative to sales [doc:HA-latest]. The company's revenue is concentrated across two business segments: Cosmetics Sales Business and Other Business. The Cosmetics Sales Business is the primary revenue driver, though the exact proportion is not disclosed. The Other Business segment includes franchise operations and real estate leasing, which may provide diversification but also introduce exposure to non-core revenue streams [doc:HA-latest]. Growth trajectory appears modest. Revenue for the latest period was KRW 85,031,829,900, with no prior-year data provided. The outlook for the current fiscal year (FY) and next FY is not explicitly stated, but the company's capital expenditure of KRW -792,951,780 suggests a focus on cost optimization rather than expansion [doc:HA-latest]. Risk assessment indicates low liquidity and dilution risk. The company has no immediate filing-based liquidity or dilution flags, and its debt-to-equity ratio of 0.16 suggests a conservative capital structure. However, the high price-to-earnings (PE) ratio of 126.01 and price-to-book (PB) ratio of 4.23 indicate that the stock is trading at a premium relative to earnings and book value, which could be a concern if earnings growth does not meet expectations [doc:valuation snapshot]. Recent events include no disclosed material filings or transcripts in the provided data. The company's financials suggest a stable but low-growth business model, with a focus on maintaining liquidity and managing operating costs [doc:HA-latest].
Key takeaways
  • Hankook Cosmetics maintains a strong liquidity position with KRW 15.9 billion in cash and equivalents.
  • The company's ROE and ROA are below industry medians, indicating subpar profitability.
  • Revenue is concentrated in two business segments, with the Cosmetics Sales Business as the primary driver.
  • Capital expenditure is negative, suggesting a focus on cost control rather than expansion.
  • The stock is trading at a premium with a high PE ratio, which may be a concern if earnings growth is insufficient.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyKRW
Revenue$85.03B
Gross profit$41.90B
Operating income$527.5M
Net income$1.13B
R&D
SG&A
D&A
SBC
Operating cash flow$2.91B
CapEx-$793.0M
Free cash flow$2.07B
Total assets$56.36B
Total liabilities$22.81B
Total equity$33.55B
Cash & equivalents$15.91B
Long-term debt$5.43B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$8840.00
Market cap$142.03B
Enterprise value$131.56B
P/E126.0
Reported non-GAAP P/E
EV/Revenue1.6
EV/Op income249.4
EV/OCF45.2
P/B4.2
P/Tangible book4.2
Tangible book$33.55B
Net cash$10.47B
Current ratio1.8
Debt/Equity0.2
ROA2.0%
ROE3.4%
Cash conversion2.6%
CapEx/Revenue-0.9%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Retailers · cohort 8 companies
Metric123690Activity
Op margin0.6%9.5% medp25 6.4% · p75 13.1%bottom quartile
Net margin1.3%8.2% medp25 5.0% · p75 11.1%bottom quartile
Gross margin49.3%35.0% medp25 33.0% · p75 44.8%top quartile
R&D / revenue0.4% medp25 0.4% · p75 0.4%
CapEx / revenue-0.9%3.4% medp25 2.9% · p75 4.6%bottom quartile
Debt / equity16.0%25.8% medp25 3.1% · p75 69.4%below median
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-05 22:25 UTC#bd824fbd
Market quoteclose KRW 8840.00 · shares 0.02B diluted
no public URL
2026-05-05 22:25 UTC#0ef22333
Source: analysis-pipeline (hybrid)Generated: 2026-05-05 22:27 UTCJob: 48f90f95